Covid-19: Pfizer vaccine ‘highly promising’, but logistical challenges remain

About This Source - FRANCE 24 English

The video item below is a piece of English language content from France 24. France 24 is a French state-owned international news television network based in Paris.

Recent from FRANCE 24 English:

  • Calls to protect civilians in Tigray as Ethiopia’s ultimatum looms
  • ‘America is back’, says Biden as he introduces new national security team
  • French businesses welcome lockdown easing
  • FRANCE 24 English published this video item, entitled “Covid-19: Pfizer vaccine ‘highly promising’, but logistical challenges remain” – below is their description.

    Amid high hopes over a vaccine being developed by Pfizer and BioNTech against the coronavirus, we speak to Dr. Anh Wartel from the International Vaccine Institute in Seoul, South Korea. She says that despite the “highly promising” results which give real hope, we need to remain “very cautious and very prudent”. Wartel says it’s incredible to be at this stage with so many vaccine alternatives being developed and she’s optimistic for the Pfizer/BioNTech vaccine, but challenges remain in terms of supply, distribution and equity.

    FRANCE 24 English YouTube Channel

    Got a comment? Leave your thoughts in the comments section, below. Please note comments are moderated before publication.

    In This Story: BioNTech

    BioNTech SE (NASDAQ: BNTX) is a German biotechnology company dedicated to the development and manufacture of active immunotherapies for a patient-specific approach to the treatment of serious diseases.

    5 Recent Items: BioNTech

  • AstraZeneca Covid Vaccine Draws Harsh Reviews from Wall Street Analysts
  • AstraZeneca-Oxford Vaccine Delivers But Can’t Match Pfizer and Moderna Results
  • Will enough people get vaccinated to stop spread of Covid? | DW News
  • Covid: First vaccine doses could be delivered next month @BBC News live – BBC
  • 1st vaccine nears finish line as COVID-19 numbers continue to rise
  • In This Story: COVID-19

    Covid-19 is the official WHO name given to the novel coronavirus which broke out in late 2019 and began to spread in the early months of 2020.

    Symptoms of coronavirus

    The main symptoms of coronavirus are:

    • a persistent new cough (non productive, dry)
    • a high temperature (e.g. head feels warm to the touch)
    • shortness of breath (if this is abnormal for the individual, or increased)

    Latest News about Covid-19

    Below are stories from around the globe related to the 2020 outbreak of novel Coronavirus – since the WHO gave the Covid-19 naming. Most recent items are posted nearest the top.

    5 Recent Items: COVID-19

  • Economy is ‘building momentum’ into the end of 2020
  • Mask vending machines in subway stations welcomed in Chinese cities
  • How will winter test efforts to curb the pandemic?
  • Hong Kong reopens Covid-19 treatment facility to tackle new wave of infections
  • Almost 200,000 people a day in the US are being diagnosed with coronavirus | 7.30
  • In This Story: Pfizer

    Pfizer Inc. (NYSE: PFE) is an American multinational pharmaceutical corporation headquartered in New York City. In 2012, it was one of the world’s largest pharmaceutical companies and ranked 57 on the 2018 Fortune 500 list of the largest United States corporations by total revenue.

    5 Recent Items: Pfizer

  • Russia says Sputnik V coronavirus vaccine 95 per cent effective
  • In full: Boris Johnson gives Downing Street press conference as local restrictions are unveiled
  • Astra-Oxford Vaccine Shows Two Different Efficacy Rates
  • AstraZeneca Covid Vaccine Draws Harsh Reviews from Wall Street Analysts
  • AstraZeneca-Oxford Vaccine Found 70% Effective in Preventing Covid
  • Leave a Comment